{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:46:52Z","timestamp":1785322012510,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ministry of Health of the Czech Republic for the conceptual development of a research organization","award":["023728"],"award-info":[{"award-number":["023728"]}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["DFF - 7016-00233"],"award-info":[{"award-number":["DFF - 7016-00233"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Danish National Mass Spectrometry Platform for Functional Proteomics","award":["5072-00007B"],"award-info":[{"award-number":["5072-00007B"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The presence or absence of autoantibodies against citrullinated proteins (ACPAs) distinguishes two main groups of rheumatoid arthritis (RA) patients with different etiologies, prognoses, disease severities, and, presumably, disease pathogenesis. The heterogeneous responses of RA patients to various biologics, even among ACPA-positive patients, emphasize the need for further stratification of the patients. We used high-density protein array technology for fingerprinting of ACPA reactivity. Identification of the proteome recognized by ACPAs may be a step to stratify RA patients according to immune reactivity. Pooled plasma samples from 10 anti-CCP-negative and 15 anti-CCP-positive RA patients were assessed for ACPA content using a modified protein microarray containing 1631 different natively folded proteins citrullinated in situ by protein arginine deiminases (PADs) 2 and PAD4. IgG antibodies from anti-CCP-positive RA plasma showed high-intensity binding to 87 proteins citrullinated by PAD2 and 99 proteins citrullinated by PAD4 without binding significantly to the corresponding native proteins. Curiously, the binding of IgG antibodies in anti-CCP-negative plasma was also enhanced by PAD2- and PAD4-mediated citrullination of 29 and 26 proteins, respectively. For only four proteins, significantly more ACPA binding occurred after citrullination with PAD2 compared to citrullination with PAD4, while the opposite was true for one protein. We demonstrate that PAD2 and PAD4 are equally efficient in generating citrullinated autoantigens recognized by ACPAs. Patterns of proteins recognized by ACPAs may serve as a future diagnostic tool for further subtyping of RA patients.<\/jats:p>","DOI":"10.1038\/s41598-021-96675-z","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T10:03:36Z","timestamp":1630058616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2577-5868","authenticated-orcid":false,"given":"Thomas B. G.","family":"Poulsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2733-8541","authenticated-orcid":false,"given":"Dres","family":"Damgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1381-3863","authenticated-orcid":false,"given":"Malene M.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ladislav","family":"Senolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8988-9595","authenticated-orcid":false,"given":"Jonathan M.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7543-9016","authenticated-orcid":false,"given":"Claus H.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-1955","authenticated-orcid":false,"given":"Allan","family":"Stensballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,27]]},"reference":[{"issue":"10","key":"96675_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrrheum.2012.134","volume":"8","author":"WP Arend","year":"2012","unstructured":"Arend, W. P. & Firestein, G. S. Pre-rheumatoid arthritis: Predisposition and transition to clinical synovitis. Nat. Rev. Rheumatol. 8(10), 573\u2013586 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"96675_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B. & van Venrooij, W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Investig. 101(1), 273\u2013281 (1998).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"96675_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens, G. A. et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43(1), 155\u2013163 (2000).","journal-title":"Arthritis Rheum."},{"issue":"2","key":"96675_CR4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen, M. M. J. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 50(2), 380\u2013386. https:\/\/doi.org\/10.1002\/art.20018 (2004).","journal-title":"Arthritis Rheum."},{"issue":"4","key":"96675_CR5","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00281-017-0620-6","volume":"39","author":"A Tracy","year":"2017","unstructured":"Tracy, A., Buckley, C. D. & Raza, K. Pre-symptomatic autoimmunity in rheumatoid arthritis: When does the disease start?. Semin. Immunopathol. 39(4), 423\u2013435. https:\/\/doi.org\/10.1007\/s00281-017-0620-6 (2017).","journal-title":"Semin. Immunopathol."},{"key":"96675_CR6","doi-asserted-by":"crossref","unstructured":"Seegobin, S. D. et al. ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: Secondary analysis of a randomized controlled trial. Arthritis Res. Ther. 16(1):R13. http:\/\/arthritis-research.com\/content\/16\/1\/R13 (2014).","DOI":"10.1186\/ar4439"},{"issue":"5","key":"96675_CR7","doi-asserted-by":"publisher","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AHM van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil, A. H. M., Verpoort, K. N., Breedveld, F. C., Toes, R. E. M. & Huizinga, T. W. J. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res. Ther. 7(5), R949\u2013R958. https:\/\/doi.org\/10.1186\/ar1767 (2005).","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"96675_CR8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar, E. R., Zendman, A. J. W., van Venrooij, W. J. & Pruijn, G. J. M. PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. BioEssays 25(11), 1106\u20131118 (2003).","journal-title":"BioEssays"},{"issue":"11","key":"96675_CR9","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.22983","volume":"56","author":"C Foulquier","year":"2007","unstructured":"Foulquier, C. et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56(11), 3541\u20133553 (2007).","journal-title":"Arthritis Rheum."},{"issue":"5","key":"96675_CR10","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/art.40035","volume":"69","author":"NE Blach\u00e8re","year":"2017","unstructured":"Blach\u00e8re, N. E. et al. High-titer rheumatoid arthritis antibodies preferentially bind fibrinogen citrullinated by peptidylarginine deiminase 4. Arthritis Rheumatol. 69(5), 986\u2013995. https:\/\/doi.org\/10.1002\/art.40035 (2017).","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"96675_CR11","doi-asserted-by":"publisher","first-page":"0203214","DOI":"10.1371\/journal.pone.0203214","volume":"13","author":"D Damgaard","year":"2018","unstructured":"Damgaard, D. et al. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3. Pizzo S V, editor. PLoS\u00a0One 13(8), 0203214. https:\/\/doi.org\/10.1371\/journal.pone.0203214 (2018).","journal-title":"PLoS\u00a0One"},{"issue":"6","key":"96675_CR12","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1186\/ar3205","volume":"12","author":"JJ van Beers","year":"2010","unstructured":"van Beers, J. J. et al. Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance. Arthritis Res. Ther. 12(6), R219. https:\/\/doi.org\/10.1186\/ar3205 (2010).","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"96675_CR13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/cei.12932","volume":"188","author":"VC Willis","year":"2017","unstructured":"Willis, V. C. et al. Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis. Clin. Exp. Immunol. 188(2), 263\u2013274 (2017).","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"96675_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1242\/dmm.010520","volume":"6","author":"MA Moscarello","year":"2013","unstructured":"Moscarello, M. A. et al. Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis. Dis. Model Mech. 6(2), 467\u2013478. https:\/\/doi.org\/10.1242\/dmm.010520 (2013).","journal-title":"Dis. Model Mech."},{"key":"96675_CR15","doi-asserted-by":"publisher","first-page":"895343","DOI":"10.1155\/2012\/895343","volume":"2012","author":"S Mohanan","year":"2012","unstructured":"Mohanan, S. et al. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem. Res. Int. 2012, 895343 (2012).","journal-title":"Biochem. Res. Int."},{"issue":"1","key":"96675_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jnr.20431","volume":"80","author":"A Ishigami","year":"2005","unstructured":"Ishigami, A. et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer\u2019s disease. J. Neurosci. Res. 80(1), 120\u2013128 (2005).","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"96675_CR17","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.berh.2015.04.010","volume":"28","author":"A Aggarwal","year":"2014","unstructured":"Aggarwal, A. Role of autoantibody testing. Best Pract. Res. Clin. Rheumatol. 28(6), 907\u2013920. https:\/\/doi.org\/10.1016\/j.berh.2015.04.010 (2014).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"96675_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.clim.2017.07.019","volume":"186","author":"T Takeuchi","year":"2018","unstructured":"Takeuchi, T. Biomarkers as a treatment guide in rheumatoid arthritis. Clin. Immunol. 186, 59\u201362 (2018).","journal-title":"Clin. Immunol."},{"issue":"5","key":"96675_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/MD.0000000000009713","volume":"97","author":"HJ Soe","year":"2018","unstructured":"Soe, H. J. et al. Identifying protein biomarkers in predicting disease severity of dengue virus infection using immune-related protein microarray. Medicine (Baltimore) 97(5), 6\u201312 (2018).","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"96675_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/biomedicines8060141","volume":"8","author":"TBG Poulsen","year":"2020","unstructured":"Poulsen, T. B. G. et al. Identification of novel native autoantigens in rheumatoid arthritis. Biomedicines 8(6):141. https:\/\/doi.org\/10.3390\/biomedicines8060141 (2020).","journal-title":"Biomedicines"},{"issue":"12","key":"96675_CR21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1080\/14737159.2020.1857734","volume":"20","author":"TBG Poulsen","year":"2020","unstructured":"Poulsen, T. B. G. et al. Protein array-based companion diagnostics in precision medicine. Expert Rev. Mol. Diagn. 20(12), 1183\u20131198. https:\/\/doi.org\/10.1080\/14737159.2020.1857734 (2020).","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"11","key":"96675_CR22","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1136\/annrheumdis-2015-208529","volume":"75","author":"MF Konig","year":"2016","unstructured":"Konig, M. F., Giles, J. T., Nigrovic, P. A. & Andrade, F. Antibodies to native and citrullinated RA33 (hnRNP A2\/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis. Ann. Rheum. Dis. 75(11), 2022\u20132028. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208529 (2016).","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"96675_CR23","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.bbrc.2015.07.161","volume":"465","author":"X Wang","year":"2015","unstructured":"Wang, X., Chen, P., Cui, J., Yang, C. & Du, H. Biochemical and biophysical research communications keratin 8 is a novel autoantigen of rheumatoid arthritis. Biochem. Biophys. Res. Commun. 465(4), 665\u2013669. https:\/\/doi.org\/10.1016\/j.bbrc.2015.07.161 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"96675_CR24","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/ard.2008.091355","volume":"68","author":"O Snir","year":"2009","unstructured":"Snir, O. et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: Association with HLA-DRB1 alleles. Ann. Rheum. Dis. 68(5), 736\u2013743. https:\/\/doi.org\/10.1136\/ard.2008.091355 (2009).","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"96675_CR25","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1136\/annrheumdis-2015-208495","volume":"75","author":"A Schwenzer","year":"2016","unstructured":"Schwenzer, A. et al. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis. Ann. Rheum. Dis. 75(10), 1876\u20131883. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208495 (2016).","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"96675_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/rheumatology\/keq419","volume":"50","author":"K Van Steendam","year":"2011","unstructured":"Van Steendam, K., Tilleman, K. & Deforce, D. The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis. Rheumatology 50(5), 830\u2013837. https:\/\/doi.org\/10.1093\/rheumatology\/keq419 (2011).","journal-title":"Rheumatology"},{"issue":"4","key":"96675_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5114\/ceji.2017.72807","volume":"42","author":"W Kurowska","year":"2017","unstructured":"Kurowska, W., Kuca-Warnawin, E. H., Radzikowska, A. & Ma\u015bli\u0144ski, W. The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Cent. J. Immunol. 42(4), 390\u2013398 (2017).","journal-title":"Cent. J. Immunol."},{"issue":"7","key":"96675_CR28","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1074\/mcp.M115.057661","volume":"15","author":"K Karthikeyan","year":"2016","unstructured":"Karthikeyan, K. et al. A contra capture protein array platform for studying post-translationally modified (PTM) Auto-antigenomes. Mol. Cell Proteom. 15(7), 2324\u20132337 (2016).","journal-title":"Mol. Cell Proteom."},{"issue":"10","key":"96675_CR29","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/art.41385","volume":"72","author":"P Sahlstr\u00f6m","year":"2020","unstructured":"Sahlstr\u00f6m, P. et al. Different hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis. Arthritis Rheumatol. 72(10), 1643\u20131657. https:\/\/doi.org\/10.1002\/art.41385 (2020).","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"96675_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/14756366.2017.1368505","volume":"32","author":"D Damgaard","year":"2017","unstructured":"Damgaard, D., Bj\u00f8rn, M. E., Jensen, P. \u00d8. & Nielsen, C. H. Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase. J. Enzyme Inhib. Med. Chem. 32(1), 1203\u20131208. https:\/\/doi.org\/10.1080\/14756366.2017.1368505 (2017).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"96675_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bbrc.2004.11.152","volume":"327","author":"M Nakayama-Hamada","year":"2005","unstructured":"Nakayama-Hamada, M. et al. Comparison of enzymatic properties between hPADI2 and hPADI4. Biochem. Biophys. Res. Commun. 327(1), 192\u2013200 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"96675_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/ard.2003.012211","volume":"63","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar, E. R. et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann. Rheum. Dis. 63(4), 373\u2013381 (2004).","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"96675_CR33","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s13075-014-0498-9","volume":"16","author":"D Damgaard","year":"2014","unstructured":"Damgaard, D., Senolt, L., Nielsen, M. F., Pruijn, G. J. & Nielsen, C. H. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Arthritis Res. Ther. 16(6), 498. https:\/\/doi.org\/10.1186\/s13075-014-0498-9 (2014).","journal-title":"Arthritis Res. Ther."},{"issue":"Suppl 2","key":"96675_CR34","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1136\/ard.2010.129577s","volume":"69","author":"A Ioan-Facsinay","year":"2010","unstructured":"Ioan-Facsinay, A. et al. Anti-CCP antibodies are a collection of ACPA that are cross-reactive to multiple citrullinated antigens. Ann. Rheum. Dis. 69(Suppl 2), A8\u2013A8. https:\/\/doi.org\/10.1136\/ard.2010.129577s (2010).","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"96675_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/art.40698","volume":"71","author":"C Ge","year":"2019","unstructured":"Ge, C. et al. Structural basis of cross-reactivity of anti-citrullinated protein antibodies. Arthritis Rheumatol. 71(2), 210\u2013221. https:\/\/doi.org\/10.1002\/art.40698 (2019).","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"96675_CR36","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/pro.2178","volume":"21","author":"NH Trier","year":"2012","unstructured":"Trier, N. H., Leth, M. L., Hansen, P. R. & Houen, G. Cross-reactivity of a human IgG 1 anticitrullinated fibrinogen monoclonal antibody to a citrullinated profilaggrin peptide. Protein Sci. 21(12), 1929\u20131941. https:\/\/doi.org\/10.1002\/pro.2178 (2012).","journal-title":"Protein Sci."},{"issue":"1","key":"96675_CR37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13075-020-02191-2","volume":"22","author":"E Reed","year":"2020","unstructured":"Reed, E. et al. Presence of autoantibodies in \u201cseronegative\u201d rheumatoid arthritis associates with classical risk factors and high disease activity. Arthritis Res. Ther. 22(1), 170. https:\/\/doi.org\/10.1186\/s13075-020-02191-2 (2020).","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"96675_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaut.2010.10.003","volume":"36","author":"K Somers","year":"2011","unstructured":"Somers, K. et al. Novel autoantibody markers for early and seronegative rheumatoid arthritis. J. Autoimmun. 36(1), 33\u201346 (2011).","journal-title":"J. Autoimmun."},{"issue":"8","key":"96675_CR39","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/rheumatology\/kew198","volume":"55","author":"LM De Winter","year":"2016","unstructured":"De Winter, L. M. et al. Autoantibodies to two novel peptides in seronegative and early rheumatoid arthritis. Rheumatology 55(8), 1431\u20131436. https:\/\/doi.org\/10.1093\/rheumatology\/kew198 (2016).","journal-title":"Rheumatology"},{"issue":"3","key":"96675_CR40","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/annrheumdis-2013-203915","volume":"74","author":"CA Wagner","year":"2013","unstructured":"Wagner, C. A. et al. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: Association with cigarette smoking and HLA-DRB1 \u2018shared epitope\u2019 alleles. Ann. Rheum. Dis. 74(3), 579\u2013586. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203915 (2013).","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"96675_CR41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00125-017-4296-1","volume":"60","author":"R Strollo","year":"2017","unstructured":"Strollo, R. et al. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children. Diabetologia 60(8), 1467\u20131474. https:\/\/doi.org\/10.1007\/s00125-017-4296-1 (2017).","journal-title":"Diabetologia"},{"issue":"5","key":"96675_CR42","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1084\/jem.185.5.843","volume":"185","author":"PJ Utz","year":"1997","unstructured":"Utz, P. J., Hottelet, M., Schur, P. H. &  Anderson, P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J. Exp. Med 185(5):843\u201354. https:\/\/doi.org\/10.1084\/jem.185.5.843 (1997).","journal-title":"J. Exp. Med"},{"issue":"9","key":"96675_CR43","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1002\/art.27552","volume":"62","author":"N Wegner","year":"2010","unstructured":"Wegner, N. et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and \u03b1-enolase: Implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 62(9), 2662\u20132672. https:\/\/doi.org\/10.1002\/art.27552 (2010).","journal-title":"Arthritis Rheum."},{"issue":"11","key":"96675_CR44","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1136\/annrheumdis-2014-205385","volume":"74","author":"MF Konig","year":"2015","unstructured":"Konig, M. F., Paracha, A. S., Moni, M., Bingham, C. O. & Andrade, F. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann. Rheum. Dis. 74(11), 2054\u20132061. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205385 (2015).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"96675_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13075-018-1520-4","volume":"20","author":"EC de Moel","year":"2018","unstructured":"de Moel, E. C. et al. Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes. Arthritis Res. Ther. 20(1), 33. https:\/\/doi.org\/10.1186\/s13075-018-1520-4 (2018).","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"96675_CR46","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1002\/art.30596","volume":"63","author":"P Lal","year":"2011","unstructured":"Lal, P. et al. Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment. Arthritis Rheum. 63(12), 3681\u20133691. https:\/\/doi.org\/10.1002\/art.30596 (2011).","journal-title":"Arthritis Rheum."},{"issue":"1","key":"96675_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","volume":"37","author":"Y Hamaguchi","year":"2010","unstructured":"Hamaguchi, Y. Autoantibody profiles in systemic sclerosis: Predictive value for clinical evaluation and prognosis. J. Dermatol. 37(1), 42\u201353. https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00762.x (2010).","journal-title":"J. Dermatol."},{"key":"96675_CR48","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10498","author":"Z Liang","year":"2019","unstructured":"Liang, Z. et al. Identification of clinically relevant subgroups of COPD based on airway and circulating autoantibody profiles. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2019.10498 (2019).","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"96675_CR49","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584 (2010).","journal-title":"Arthritis Rheum."},{"key":"96675_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-94-007-5811-7","volume-title":"Bioinformatics of Human Proteomics, Vol ***3","author":"J Duarte","year":"2013","unstructured":"Duarte, J., Serufuri, J., Mulder, N. & Blackburn, J. Bioinformatics of Human Proteomics, Vol 3 39\u201374 (Springer, 2013). https:\/\/doi.org\/10.1007\/978-94-007-5811-7."},{"issue":"9","key":"96675_CR51","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1097\/MIB.0000000000000460","volume":"21","author":"TB Bennike","year":"2015","unstructured":"Bennike, T. B. et al. Neutrophil extracellular traps in ulcerative colitis. Inflamm. Bowel Dis 21(9):2052\u201367. https:\/\/doi.org\/10.1097\/MIB.0000000000000460. (2015).","journal-title":"Inflamm. Bowel Dis"},{"issue":"D1","key":"96675_CR52","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: Improving support for quantification data. Nucleic Acids Res. 47(D1), D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96675-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96675-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:11:29Z","timestamp":1670073089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96675-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96675"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96675-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,27]]},"assertion":[{"value":"19 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JMB is the Chief Scientific Officer of Sengenics Corporation who commercializes the Immunome arrays used in this study. TP, DD, MJ, CN, AS, and LS declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17300"}}